|
PTPRG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.422890E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.88890000000819E-05 |
| Normal-vs-Stage2 |
8.822100E-03 |
| Normal-vs-Stage3 |
4.341400E-01 |
| Normal-vs-Stage4 |
4.31619999999855E-05 |
| Stage1-vs-Stage2 |
9.271800E-01 |
| Stage1-vs-Stage3 |
2.149000E-01 |
| Stage1-vs-Stage4 |
5.014400E-02 |
| Stage2-vs-Stage3 |
3.154000E-01 |
| Stage2-vs-Stage4 |
2.005200E-01 |
| Stage3-vs-Stage4 |
2.559900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.213500E-04 |
| Normal-vs-AfricanAmerican |
5.842700E-04 |
| Normal-vs-Asian |
6.978200E-04 |
| Caucasian-vs-AfricanAmerican |
7.302600E-01 |
| Caucasian-vs-Asian |
3.836000E-02 |
| AfricanAmerican-vs-Asian |
3.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54039999999966E-06 |
| Normal-vs-Female |
5.384600E-01 |
| Male-vs-Female |
1.004630E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.783100E-03 |
| Normal-vs-Extreme_Weight |
1.53599999996867E-06 |
| Normal-vs-Obese |
1.264410E-01 |
| Normal-vs-Extreme_Obese |
1.438320E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.840000E-01 |
| Normal_Weight-vs-Obese |
2.045200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.599970E-01 |
| Extreme_Weight-vs-Obese |
1.012130E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.443000E-01 |
| Obese-vs-Extreme_Obese |
1.118420E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.945000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.531970E-02 |
| Normal-vs-Age(61-80Yrs) |
1.40270000004161E-06 |
| Normal-vs-Age(81-100Yrs) |
8.839200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.974400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.160600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.166200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.356160E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.991600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.982600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.84659999999237E-05 |
| Normal-VS-Type2 PRCC |
2.177500E-04 |
| Normal-VS-KIRP CIMP |
9.268000E-01 |
| Normal-VS-Unclassified PRCC |
3.769800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.973400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.153400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.477640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.957630E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.321210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.828000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.4742000000042E-05 |
| Normal-vs-N1 |
2.297400E-01 |
| Normal-vs-N2 |
4.983400E-03 |
| N0-vs-N1 |
2.824200E-01 |
| N0-vs-N2 |
5.574200E-01 |
| N1-vs-N2 |
4.032800E-01 |
|
|
